Stefan Orwat1, Gerhard-Paul Diller1, Aleksander Kempny1, Robert Radke1, Brigitte Peters2, Titus Kühne3, Dietmar Boethig4, Matthias Gutberlet5, Karl-Otto Dubowy6, Philipp Beerbaum4, Samir Sarikouch7, Helmut Baumgartner1. 1. Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany. 2. Institute for Biometry and Medical Informatics, University of Magdeburg, Magdeburg, Germany. 3. Department of Congenital Heart Disease/Pediatric Cardiology, German Heart Center Berlin, Germany. 4. Department of Pediatric Cardiology and Pediatric Intensive Care, Hannover Medical School, Hannover, Germany. 5. Department of Diagnostic and Interventional Radiology, Heart Center, University of Leipzig, Leipzig, Germany. 6. Department of Paediatric Cardiology, Heartcenter of North Rhine-Westphalia, University of Bochum, Bad Oeynhausen, Germany. 7. Department of Heart-, Thoracic-, Transplantation- and Vascular Surgery, Hannover Medical School, Germany.
Abstract
BACKGROUND: Parameters of myocardial deformation have been suggested to be superior to conventional measures of ventricular function and to predict outcome in repaired tetralogy of Fallot (ToF). We aimed to test the hypothesis that parameters of myocardial deformation on cardiac MRI (CMR) relate to symptoms and provide prognostic information in patients with repaired ToF. METHODS AND RESULTS: We included 372 patients with ToF (median age 16 years; 55% male), recruited within a nationwide, prospective study. Longitudinal (LS), circumferential (CS) and radial global strain (RS) were analysed by CMR-based feature tracking (FT). A combined endpoint of death, successful resuscitation or documented ventricular tachycardia was employed. Parameters of global strain were associated with New York Heart Association (NYHA) class and symptomatic deterioration. During a median follow-up of 7.4 years, 20 events occurred. Left ventricular (LV) CS and right ventricular (RV) LS emerged as predictors of outcome, independent of QRS duration, LV/RV ejection fraction and volumes, NYHA class and peak oxygen uptake. In combination, these parameters also identified a subgroup of patients at significantly increased risk of adverse of outcomes (HR 3.3, p=0.002). Furthermore, LV LS, RS, CS and RV LS were related to the risk of death and nearly missed death (p<0.05 for all). CONCLUSIONS: FT-CMR provides myocardial deformation parameters, easily derived from standard CMR studies. They relate to symptoms and clinical deterioration in patients with ToF. More importantly, they predict adverse outcome independent of established risk markers, and should be considered as a useful adjunct to established outcome predictors, especially in younger patients with ToF. CLINICAL TRIAL REGISTRATION NUMBER: http://www.clinicaltrials.gov: NCT00266188; Results. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND: Parameters of myocardial deformation have been suggested to be superior to conventional measures of ventricular function and to predict outcome in repaired tetralogy of Fallot (ToF). We aimed to test the hypothesis that parameters of myocardial deformation on cardiac MRI (CMR) relate to symptoms and provide prognostic information in patients with repaired ToF. METHODS AND RESULTS: We included 372 patients with ToF (median age 16 years; 55% male), recruited within a nationwide, prospective study. Longitudinal (LS), circumferential (CS) and radial global strain (RS) were analysed by CMR-based feature tracking (FT). A combined endpoint of death, successful resuscitation or documented ventricular tachycardia was employed. Parameters of global strain were associated with New York Heart Association (NYHA) class and symptomatic deterioration. During a median follow-up of 7.4 years, 20 events occurred. Left ventricular (LV) CS and right ventricular (RV) LS emerged as predictors of outcome, independent of QRS duration, LV/RV ejection fraction and volumes, NYHA class and peak oxygen uptake. In combination, these parameters also identified a subgroup of patients at significantly increased risk of adverse of outcomes (HR 3.3, p=0.002). Furthermore, LV LS, RS, CS and RV LS were related to the risk of death and nearly missed death (p<0.05 for all). CONCLUSIONS: FT-CMR provides myocardial deformation parameters, easily derived from standard CMR studies. They relate to symptoms and clinical deterioration in patients with ToF. More importantly, they predict adverse outcome independent of established risk markers, and should be considered as a useful adjunct to established outcome predictors, especially in younger patients with ToF. CLINICAL TRIAL REGISTRATION NUMBER: http://www.clinicaltrials.gov: NCT00266188; Results. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Shafkat Anwar; Matthew A Harris; Kevin K Whitehead; Marc S Keller; Elizabeth Goldmuntz; Mark A Fogel; Laura Mercer-Rosa Journal: Pediatr Cardiol Date: 2017-01-31 Impact factor: 1.655
Authors: Alexander Ruh; Roberto Sarnari; Haben Berhane; Kenny Sidoryk; Kai Lin; Ryan Dolan; Arleen Li; Michael J Rose; Joshua D Robinson; James C Carr; Cynthia K Rigsby; Michael Markl Journal: Int J Cardiovasc Imaging Date: 2019-02-04 Impact factor: 2.357
Authors: Maria Sanz-de la Garza; Geneviève Giraldeau; Josefa Marin; Sebastian Imre Sarvari; Eduard Guasch; Luigi Gabrielli; Carlos Brambila; Bart Bijnens; Marta Sitges Journal: Int J Cardiovasc Imaging Date: 2019-05-25 Impact factor: 2.357
Authors: Manar D Samad; Gregory J Wehner; Mohammad R Arbabshirani; Linyuan Jing; Andrew J Powell; Tal Geva; Christopher M Haggerty; Brandon K Fornwalt Journal: Eur Heart J Cardiovasc Imaging Date: 2018-07-01 Impact factor: 6.875
Authors: Jouke P Bokma; Koen C de Wilde; Hubert W Vliegen; Arie P van Dijk; Joost P van Melle; Folkert J Meijboom; Aeilko H Zwinderman; Maarten Groenink; Barbara J M Mulder; Berto J Bouma Journal: JAMA Cardiol Date: 2017-06-01 Impact factor: 14.676
Authors: Karena Wu; Sunkyung Yu; Adam L Dorfman; Ray Lowery; Prachi P Agarwal; Maryam Ghadimi Mahani; Jimmy C Lu Journal: Pediatr Cardiol Date: 2019-07-25 Impact factor: 1.655
Authors: Michael Huntgeburth; Ingo Germund; Lianne M Geerdink; Narayanswami Sreeram; Floris E A Udink Ten Cate Journal: Cardiovasc Diagn Ther Date: 2019-10